| Literature DB >> 35633977 |
JinBao Han1,2,3, Gang Liu1,2,3, MengNan Yu1, Guang Li1, JianYing Cao1, Lian Duan1, LiuMing Huang1,2,3.
Abstract
Background: To explore the surgical outcomes between patients with perforated and non-perforated neonatal necrotizing enterocolitis (NEC) and identify indications for surgical intervention.Entities:
Keywords: Bell stage; mortality; necrotizing enterocolitis; non-perforation and perforation; surgery
Year: 2022 PMID: 35633977 PMCID: PMC9136447 DOI: 10.3389/fped.2022.768107
Source DB: PubMed Journal: Front Pediatr ISSN: 2296-2360 Impact factor: 3.569
Comparison of preoperative factors in the non-perforated and the perforated groups [n (%), M (min, max)].
|
|
|
|
|
| |
|---|---|---|---|---|---|
| Gestational age, week | 31 (25–36) | 30 (25–36) | 31 (26–36) | −1.477 | 0.140 |
| Birth weight, g | 1650 (500–3485) | 1600 (610–3485) | 1860 (500–3160) | −0.805 | 0.421 |
| Cholestasis | 191 (70.5) | 143 (76.1) | 48 (57.8) | 9.2 | 0.002 |
| time from NEC diagnosis to surgery, h | 26 (3–82) | 29 (4–82) | 22 (3–76) | −2.267 | 0.023 |
| PDA | 103 (38) | 68 (36.2) | 35 (42.2) | 0.879 | 0.348 |
| Intrauterine infection | 186 (68.6) | 125 (66) | 61 (73) | 1.31 | 0.252 |
| Thrombocytopenia | 130 (21–404) | 139 (21–404) | 128 (28–379) | −0.051 | 0.959 |
| Leukocyte | 6.6 (1.9–29.4) | 6.6 (1.9–29.4) | 6.1 (2.3–26.4) | −1.471 | 0.141 |
| CRP | 59 (1–292) | 60 (1–234) | 59 (1–292) | −0.872 | 0.383 |
Cholestasis: total bilirubin is elevated, direct bilirubin > 17μmol/L;
PDA: Patent Ductus Arteriosus;
Platelets decrease below normal value: platelet count < 1001 × 0
White Blood Cell normal value 4.0–10.0 * 104
, CRP normal value 0–8mg/L;
There is a statistical difference.
Post-operative results between two groups [n (%), M (min, max)].
|
|
|
|
|
| |
|---|---|---|---|---|---|
| Death (30-day mortality), n | 81 (29.8) | 57 (30.3) | 24 (28.9) | 0.003 | 0.956 |
| Serious postoperative complications, | 97 (35.8) | 68 (36.4) | 29 (34.9) | 0.42 | 0.517 |
| Postoperative infection time, d | 13 (1–49) | 15 (1–49) | 12 (1–27) | −1.238 | 0.216 |
| Parenteral nutrition time, d | 29 (1–94) | 32 (3–94) | 23 (1–53) | −2.923 | 0.003 |
| Enteral nutrition time, d | 25 (0–86) | 27 (0–86) | 18 (0–81) | −2.159 | 0.03 |
| Length of NICU time, d | 40 (1–125) | 44 (5–125) | 29 (1–92) | −2.710 | 0.007 |
| Ventilator use time, d | 4 (1–28) | 4 (1–24) | 3 (1–28) | −1.854 | 0.064 |
| Length of intestinal necrosis, cm | 12 (0–92) | 15 (0–92) | 10 (2–70) | −2.464 | 0.014 |
Severe complications: at least one of acute respiratory distress syndrome, intracranial hemorrhage, and acute renal insufficiency;
Duration of postoperative infection: from the beginning of use to the degradation of antibiotics when the infection improves;
Parenteral nutrition time: from the start of intravenous nutrition to the stop;
Enteral nutrition time: from start to full dose;
There is a statistical difference.
Death in different Bell stages [n (%)].
|
|
|
|
|
|
|---|---|---|---|---|
| Cure | 13 | 78 | 40 | 59 |
| Death | 3 (18.8) | 21 (21.2) | 33 (45.2) | 24 (28.9) |
|
| 0.125 | 0.437 | 4.445 | - |
|
| 0.612 | 0.513 | 0.035 | - |
Multivariate proportional hazards analysis for survival at 30 days.
|
|
|
|
|---|---|---|
| Gestational age, wk | 0.918 (0.819–1.030) | 0.145 |
| Birth weight, g | 1.000 (0.999–1.001) | 0.613 |
| Length of intestinal necrosis, cm | 1.017 (1.010–1.024) | 0.000 |
| Postoperative infection time, d | 0.937 (0.897–0.979) | 0.003 |
| Parenteral nutrition time, d | 1.031 (0.981–1.083) | 0.225 |
| Enteral nutrition time, d | 0.916 (0.882–0.952) | 0.000 |
| Length of NICU time, d | 0.986 (0.948–1.025) | 0.478 |
| The non–perforated group | ||
| (VS. the perforated group) | 2.288 (1.329–3.940) | 0.003 |
P <0.05; CI, confidence interval.
Figure 1Survival at 30 days outcome of the non-perforated vs. the perforated groups. The mortality occurred earlier in the non-perforated group than the perforated group.